2025-04-08 17:42:52
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Emmessar Biotech and Nutrition posts PAT of Rs. 16.92 lakhs in Q3FY22
Posted On : 2022-02-12 11:44:59( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 0.5670 crores during the period ended December 31, 2021 as compared to Rs. 0.4629 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.1692 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.1835 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.34 for the period ended December 31, 2021 as compared to Rs. 0.37 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 0.5670 crs | ₹0.4629 crs |  22.49% |
| Net Profit | ₹0.1692 crs | ₹0.1835 crs |  -7.79% |
| EPS | ₹0.34 | ₹0.37 | -8.11% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 0.5670 crores during the period ended December 31, 2021 as compared to Rs.1.6478 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.1692 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.4506 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.34 for the period ended December 31, 2021 as compared to Rs.0.90 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 0.5670 crs | ₹1.6478 crs | -65.59% |
| Net Profit | ₹0.1692 crs | ₹0.4506 crs | -62.45% |
| EPS | ₹0.34 | ₹0.90 | -62.22% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1.4312 crores during the 9 Months period ended December 31, 2021 as compared to Rs.3.5728 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.4407 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.9338 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.88 for the 9 Months period ended December 31, 2021 as compared to Rs.1.87 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹1.4312 crs | ₹3.5728 crs | -59.94% |
| Net Profit | ₹0.4407 crs | ₹0.9338 crs | -52.81% |
| EPS | ₹0.88 | ₹1.87 | -52.94% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 30.85 as compared to the previous close of Rs. 30.90. The total number of shares traded during the day was 1624 in over 36 trades.
The stock hit an intraday high of Rs. 32.80 and intraday low of 29.45. The net turnover during the day was Rs. 50070.00.
